Valley National Bancorp Announces New General Counsel
"We are excited to welcome Lyndsey to Valley," said Valley CEO Ira Robbins. "Lyndsey's deep experience in banking, governance, and complex transactions will help Valley navigate an evolving landscape as we continue to deliver relationship-driven service and solutions to our clients."
Ms. Sloan brings over two decades of legal and leadership experience in the financial services and technology sectors. Most recently, she served as Deputy General Counsel at The Huntington National Bank, where she led a 30-attorney team advising across business lines and functions. Her background includes overseeing regulatory relations, advising on numerous transactions, launching an enterprise-wide patent program to support innovation, and serving as Corporate Secretary to the Board of Directors.
Earlier in her career, Ms. Sloan was General Counsel for Global Technology Finance and for a global software company, where she helped lead the sale of the business to its largest competitor.
"I am excited to join Valley's talented leadership team and to contribute to the incredible culture formed by nearly 100 years in banking," said Ms. Sloan. "I look forward to collaborating with the leadership team to deliver value to Valley's customers, communities, associates, and shareholders."
Ms. Sloan succeeds Gary Michael, who has retired after more than 19 years of dedicated service to Valley.
About Valley
As the principal subsidiary of Valley National Bancorp, Valley National Bank is a regional bank with $62 Billion in total assets. Valley is committed to giving people and businesses the power to succeed. Valley operates many convenient branch locations and commercial banking offices across New Jersey, New York, Florida, Alabama, California, and Illinois, and is committed to providing the most convenient service, the latest innovations and an experienced and knowledgeable team dedicated to meeting customer needs. Helping communities grow and prosper is the heart of Valley's corporate citizenship philosophy. To learn more about Valley, go to www.valley.com or call our Customer Care Center at 800-522-4100.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250701502271/en/
Contacts
Pam Golden(973) 564-8591pam@glapr.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Powell Blames Rate-Cut Delays on Tariffs
The halfway point of 2025 is today at noon, which marks 182.5 days into the 365-day year. The benchmark S&P 500 is up 5.4% so far, even after taking a Greg Louganis-worthy 19% dive in April following President Donald Trump's 'Liberation Day' tariff announcement. Federal Reserve officials, meanwhile, have held off on interest rate cuts — to Trump's everlasting chagrin. On Tuesday, Federal Reserve Chair Jerome Powell gave his most forceful statement yet blaming the tariffs for the hold-up, but he also left some wiggle room for the next 182.5 days. READ ALSO: Ford, GM Notch Sales Surge as Detroit Braces for Slump and Home Depot Acquires Building Products Distributor GMS The S&P 500 notched its first record high in more than four months on Friday. It marked an encouraging sign that markets are no longer especially concerned with the worst-case scenarios initially imagined when Trump announced he would rain tariffs on trading partners. The effective US tariff rate, based on policies announced this year, is now 13%, up from 3% at the start of the year, according to Goldman Sachs. Nevertheless, it's a far cry from the tumultuous but mercifully brief days of 145% tariffs on China in April. Speaking to the European Central Bank forum in Sintra, Portugal, on Tuesday, Powell said, as explicitly as ever, that the trade tumult of 2025 is the reason the Fed hasn't cut rates: 'We went on hold when we saw the size of the tariffs, and essentially all inflation forecasts for the United States went up materially as a consequence of the tariffs.' The Fed has kept its key borrowing rate steady at 4.25% to 4.5% since December, though officials have suggested it could be lowered to 3.5% in the next year if inflation eases. The latest projections from the Fed's policy-setting Federal Open Market Committee hint at two cuts before the year is out. Tuesday saw economic data that, for better or worse, could encourage intervention: Core prices rose 2.7% in May, the Commerce Department announced last week, which is slightly above the Fed's 2% inflation target, a primary concern related to their rate-setting. But Tuesday saw mixed signals from the labor market: The Bureau of Labor Statistics said job openings rose in May by 374,000 to 7.77 million, the most since November, but actual hires fell 112,000 to 5.5 million. Manufacturing, meanwhile, contracted for the fourth month in a row in June, according to the Institute for Supply Management. In addition to stable inflation, a weakening economy could prompt the Fed to cut rates to stimulate activity, which would, in either case, make borrowing money cheaper for firms. Powell said a 'solid majority' of Fed officials believe it 'will become appropriate later this year to begin to reduce rates again' and left the door open to taking policy action at any time, stating he 'wouldn't take any meeting off the table or put it directly on the table.' Don't Bet On It: A rate cut at the Fed's monetary policy meeting later this month seems unlikely, although jobs data due Thursday will undoubtedly impact officials' thinking. Investors see a 78.8% chance that rates will be held steady at the July 29-30 meeting, according to CME Fedwatch. This post first appeared on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Millions in Insider Buying Point to These 2 Stocks — Here's What It Could Signal
There's a current of optimism in the air as Wall Street's stock markets climb back to record levels, with the S&P 500 hitting an all-time high yesterday. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. In this environment, it's tempting to just start buying, but a smart investor will still take a moment to pause, check the signals, and find the right stock. Few market signals come in clearer than insider buys, and for good reason. These corporate officers, residents of C-suites and Boards of Directors, know the inside workings of their companies – and when that knowledge informs their stock purchases, investors should all take note. The insiders might sell for a multitude of reasons, but they only buy for one: they believe the shares are going to jump. And when insiders start buying millions worth of their own stock, investors should definitely pay closer attention. We've used the Insiders' Hot Stocks tool from TipRanks to do just that. We've found two stocks that are showing millions of dollars' worth of insider buying. Let's give these names a closer look and find out just why the insiders are scooping them up. Vera Therapeutics (VERA) We'll start with Vera Therapeutics, one of the many clinical-stage biopharmaceutical companies working on the new drugs and therapeutic agents that have so revolutionized modern medicine in recent decades. Vera's focus is on new treatments for dangerous immunological conditions, particularly those that have both high unmet medical needs and a lack of effective treatments currently on the market. The company is developing novel biologic molecules as treatment agents in this field. Currently, Vera has one leading late-stage drug candidate in the clinical pipeline. This drug, atacicept, is under investigation as a treatment for IgA nephropathy (called IgAN, or Berger's disease), as well as for lupus nephritis. The IgAN track is the company's most advanced program, and has recently achieved several milestones. During Q1 of this year, Vera completed enrollment of the pivotal Phase 3 ORIGIN trial of atacicept in the treatment of IgAN, and began enrolling patients in the ORIGIN EXTEND study, which continued dosing and monitoring of atacicept in patients from the Phase 2b and Phase 3 ORIGIN trials. ORIGIN EXTEND will also capture longer-term data on safety and efficacy. Earlier this month, the company announced that atacicept had met the primary endpoint of the ORIGIN Phase 3 trial at week 36. Following up on the successes of the atacicept clinical trial program, Vera has plans to submit a Biologics License Application, or BLA, to the FDA during 4Q25. The company hopes to have an accelerated approval process and to potentially see a PDUFA date and the launch of commercialization activities sometime next year. Despite these developments, VERA shares have shed 44% year-to-date and evidently one insider thinks it is time to pounce. Recently, Patrick Enright, of Vera's Board of Directors, purchased 250,000 shares of VERA, in two purchases that are worth a combined $5.89 million at current valuations. Mr. Enright's stake in Vera currently totals some $148 million. This stock has caught the attention of Goldman Sachs analyst Paul Choi, who is impressed by the company's advances on the IgAN track and sees Vera as a solid choice as a potential merger target going forward. Choi writes, 'While the landscape in IgAN remains competitive, we continue to view VERA's atacicept as a clinically differentiated asset with a largely derisked profile… We have evaluated VERA shares from an M&A perspective given what we think there could be potential interest from a strategic acquirer due to the attractiveness of its end markets and pipeline assets. We assign an M&A rank of 1 (representing high (30%-50%) probability of the company becoming an acquisition candidate), and apply an 11.0x multiple on the second full year of sales (2028 given our modeled launch in 3Q26), in line with similar biotech of this stage, and arrive at a theoretical M&A valuation of $65 per share.' Choi follows this stance by setting a Buy rating on VERA, and although his $55 price target is not as high as that 'theoretical M&A valuation,' the figure still points toward a robust one-year upside potential of 133.5%. (To watch Choi's track record, click here) This stock has 12 recent analyst reviews, breaking down 11 to 1 in favor of Buy over Hold, giving it a Strong Buy consensus rating. The share price of $23.56 and average target of $66.58 together imply an upside of a hefty 182.5% in the next 12 months. (See VERA stock forecast) Marriott Vacations Worldwide (VAC) Will pivot now to an entirely different industry. The second stock we'll look at, Marriott Vacations Worldwide, is the timeshare entity built on the foundation of the hotel industry's famous Marriott name. The company was formed in 2011, when it spun off from its Marriott parent and took that company's vacation ownership and timeshare business public as an independent vacation company. Currently, Marriott Vacations Worldwide operates several brands in its vacation ownership portfolio, including (but not limited to) Marriott Vacation Club, Sheraton Vacation Club, Westin Vacation Club, and the Grand Residences by Marriott. The businesses in this portfolio offer members the ability to choose from a variety of flexible vacation programs, of differing styles, to meet their evolving needs and desires year after year. Marriott Vacations Worldwide has over 120 resorts in its portfolio, with more than 18,000 vacation villas. Vacation destinations include the US, the Caribbean, and Central America, as well as Europe, Asia, and Australia. The company's exchange and third-party management segment includes the Interval International and Aqua-Aston Hospitality brands. These subsidiaries operate vacationer membership programs, giving members access to full-service resorts around the world. Marriott Vacations Worldwide can give its members ownership rights in more than 3,200 resorts located in 80 countries. Looking at some of the company's numbers, we find that Marriott Vacations Worldwide can boast more than 700,000 member-owners on its vacation ownership side, and more than 1.5 million members on the exchange and third-party management side. The company's operations generated $1.2 billion in revenue during 1Q25, the last period reported, a figure that was flat year-over-year and missed the forecast by a mere $7.15 million. The company's earnings in the quarter came to $1.66 per share by non-GAAP measures, beating the forecast by 23 cents per share. This stock has also underperformed so far this year, shedding 17.5% of its value, but one insider must be feeling very confident in VAC's trajectory. On June 17 and 18, Christian Asmar, one of the company's Directors, bought 750,000 shares of VAC in two tranches. His combined purchase is now worth ~$54.2 million. The company has a supporter in Barclays analyst Brandt Montour, who explains why VAC currently has a favorable risk-reward profile. He writes, 'Coming off a long string of tougher quarters, management credibility around execution remains relatively low; however, in the current situation, a de-risked top-line outlook, favorable delinquency trends (corresponding to a higher-income average customer), and washed out sentiment isn't a terrible relative set-up vs. peers. For longer-term shareholders, we believe VAC's valuation remains too cheap to ignore, at <5x our 2026 EBITDA figures.' The analyst goes on to rate these shares as Overweight (i.e., Buy), and he complements that rating with an $88 price target that suggests an upside potential of 22% in the year ahead. (To watch Montour's track record, click here) The 7 recent analyst reviews on this stock include 4 Buys, 2 Holds, and 1 Sell for a Moderate Buy consensus rating. The shares have a current trading price of $72.31 and an average target price of $81.67; together, these imply that the stock will gain 13% by this time next year. (See VAC stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue
Yahoo
35 minutes ago
- Yahoo
Santander agrees to acquire TSB from Sabadell
Banco Santander has reached an agreement to acquire TSB Banking Group from Sabadell in an all-cash deal valued at up to £2.9bn. The deal values TSB at five times its expected 2026 net income. However, shareholders will be asked to initially approve a £2.65bn deal. The final price is expected to adjust to £2.9bn, incorporating estimated profits from the agreement date until the anticipated completion in the first quarter of 2026. Sabadell will seek approval for the sale along with an extraordinary cash dividend of €0.50 per share, equivalent to approximately €2.5bn, at the general shareholders' meeting on 6 August. Proceeds from the transaction will fund this dividend. TSB, a UK retail bank, operates 218 branches and serves approximately 5 million customers in personal and small business banking, with £34bn in mortgages and £35bn in deposits. The transaction is expected to yield a return on invested capital exceeding 20% and increase Santander UK's return on tangible equity from 11% in 2024 to 16% by 2028. At the group level, earnings per share accretive for Santander from the first year and of 4% in 2028. The combined entity will have a loan-to-deposit ratio of 107%, compared to Santander UK's current 108%. Santander executive chair Ana Botín said: "The acquisition of TSB represents a continuing strategic commitment to our customers in the UK, offering a compelling opportunity that is financially attractive to our shareholders and aligned with Santander's long-term objectives. It strengthens our franchise in a core market through the acquisition of a low-risk and complementary business that adds to our diversification.' Sabadell Chairman Josep Oliu stated: 'This transaction benefits our shareholders regardless of the outcome of the takeover bid. 'If approved by the General Meeting, the deal will proceed even if the bid is withdrawn.' 'As I have reiterated, Banco Sabadell is a bank with a clear focus on Spain. We offer the highest dividend yield among Spanish banks, have delivered the strongest share price performance over the past four and a half years, and have a strong future as an independent entity serving our customers.' The acquisition comes at a time when BBVA pursues a takeover bid for Sabadell, which faces government restrictions preventing a full merger for at least three years. The sale of TSB has drawn media attention for potentially limiting BBVA's access to a key asset in its acquisition strategy. "Santander agrees to acquire TSB from Sabadell " was originally created and published by Retail Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
